ACTRN12607000244404招募中1 期
Intravitreous Avastin to improve visual acuity and arrest ocular neovascularization in patients with Age related Macular Degeneration and Severe Diabetic Retinopathy and neovascular glaucoma.
Royal Victorian Eye and Ear Hospital0 个研究点目标入组 50 人开始时间: 2007年5月8日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •1. Neovascular Age related macular degeneration.2. Neovascular glaucoma3. Proliferative diabetic retinopathy4. subjects able to give informed consent.
排除标准
- •1. History of unstable cardiovascular disease (CVA, TIA or AMI)2. Previous treatment with Lucentis3. Intravenous treatment with Avastin for systemic malignancy4. Inability to read and fully understand detailed consent form5. first eyes in patients with AMD6. allergy to AvastinCVA- strokeAMI-heart attackTIA- mini-stroke.
研究者
相似试验
Unknown
不适用
The Effectiveness of Intravitreal Avastin Injection for CRVOCentral Retinal Vein OcclusionNCT01678248Ziv Hospital68
招募中
不适用
Clinical study of the Avastin intravitreal injection to thick macula after surgery of epiretinal membraneEpiretinal MembraneJPRN-UMIN000015286Okayama University Hospital30
已完成
不适用
Treatment With Intravitreal Avastin for Large Uveal MelanomasUveal MelanomaNCT00596362Memorial Sloan Kettering Cancer Center1
已完成
不适用
The effects of ?Avastin in patients with age-related macular degeneratioage-related macular degeneration.Visual disturbances and blindnessH53,H54IRCT2014070218323N1Birjand University of Medical Sciences76
已完成
3 期
Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical TrialRetinal DiseaseNCT00370851Shahid Beheshti University of Medical Sciences82